Figure 3
From: C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms
(A) Serum CMW levels in patients with control (n = 52) and patients with T-MPN (n = 34). The circles show CMW levels, and red line shows the medians. (B) Excluding patients with grade 3b and higher chronic kidney disease, the serum CMW levels of patients with control (n = 52) and those with T-MPN (n = 25). (C) The receiver operating characteristic (ROC) curve of serum CMW levels to the differential diagnoses for patients with T-MPN (n = 34). The area under curve (AUC) was 0.702; sensitivity, 0.529; and specificity, 0.846. Based on these values, the CMW cutoff value was 451.4 nM. *p < 0.05, **p < 0.01.
